Clariane SE (LTS:0OPS) Moat Score: 5/10 (As of Jul. 01, 2026)


LTS:0OPS Clariane SE LTS:0OPS
61 GF Score
Price €4.16
GF Value €2.46
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Moat Score?

Clariane SE LTS:0OPS +1.41% 61 Moat Score is 5 as of Jul. 01, 2026. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.46 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Clariane SE ranks better than 96.02% on this metric.

Clariane SE has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Clariane SE has Narrow Moat: Clariane SE benefits from a solid narrow moat with a strong brand and customer loyalty in its healthcare services. It has some pricing power and regulatory barriers, but lacks the scale or network effects to be considered a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Clariane SE might have Narrow Moat - Solid narrow moat.

Clariane SE  (LTS:0OPS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Clariane SE Moat Score Related Terms

LTS:0OPS vs HCA, THC, DVA: Moat Score Comparison

For the Medical Care Facilities subindustry, Clariane SE's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clariane SE Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Moat Score distribution charts can be found below:

* The bar in red indicates where Clariane SE's Moat Score falls into.


LTS:0OPS
61GF Score
Clariane SE LTS:0OPS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Clariane SE (LTS:0OPS) has a Moat Score of 5 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Clariane SE ranks #27 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is Clariane SE's Moat Score too high?
Clariane SE's current Moat Score is 5. Based on the distribution chart, Clariane SE ranks #27 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Moat Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #27 out of 679 companies for Moat Score. This places Clariane SE in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Clariane SE's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.46, compared to a current price of €4.16 — trading 69.2% above its estimated fair value. The current Moat Score is 5. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Moat Score is 5 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (LTS:0OPS) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.16 is trading 69.2% above its estimated GF Value™ of €2.46. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for LTS:0OPS:

  • Moat Score: 5
  • GF Value™: €2.46 vs. price of €4.16 (69.2% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for LTS:0OPS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.16
Price
€2.46
GF Value